H.C. Wainwright Upgrades AVEO Pharmaceuticals (AVEO) to Buy
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Price: $15.00 --0%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth upgraded AVEO Pharmaceuticals (NASDAQ: AVEO) from Neutral to Buy with a price target of $1.75 (from $1.00).
For an analyst ratings summary and ratings history on AVEO Pharmaceuticals click here. For more ratings news on AVEO Pharmaceuticals click here.
Shares of AVEO Pharmaceuticals closed at $0.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
